Challenges in the Management of Blood Diseases during COVID-19 Pandemic
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: closed (30 January 2023) | Viewed by 33278
Special Issue Editor
Interests: thrombosis; bleeding; hypercoagulability; clot waveform; platelet; coagulation
Special Issue Information
Dear Colleagues,
Coronavirus disease 2019 (COVID-19), which sometimes causes acute respiratory distress syndrome (ARDS), coagulopathy, and poor outcomes, has now spread worldwide. However, this does not mean that we can afford to discontinue the management of blood diseases.
In this Special Issue, we will focus on the management of blood disease during COVID-19 and would like to examine the effect of COVID-19 on blood diseases (with and without modification of frequency, pathophysiology, diagnosis, and treatments).
The virus that causes COVID-19 first emerged in China in December 2019, but COVID-19 infections spread worldwide rapidly, with the disease being declared a pandemic in less than a few months by the WHO. Various reports suggest that one of the potential symptoms of COVID-19 is the presence of coagulopathy.
New mechanisms of associated, affected, or modified blood diseases with COVID-19 will be investigated in this Special Issue.
In the context of the COVID-19 pandemic, new, modified, or constant management for various blood diseases will be required, including not just COVID-19-associated blood disease but also the blood diseases that existed before the pandemic. We look forward to receiving your articles on these topics.
Dr. Hideo Wada
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- coagulopathy
- blood diseases
- modified management
- pathophysiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.